SIRT1 and prostate carcinoma: It has been shown that SIRT1 positive expression is strongly associated with tumorigenesis and tumor progression in various cancer types, such as colorectal cancer [14], gastric carcinoma [15], prostate cancer [16], lung cancer [17], and breast cancer [18].